206 related articles for article (PubMed ID: 27084884)
1. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.
Song X; Chen J; Zhao M; Zhang C; Yu Y; Lonard DM; Chow DC; Palzkill T; Xu J; O'Malley BW; Wang J
Proc Natl Acad Sci U S A; 2016 May; 113(18):4970-5. PubMed ID: 27084884
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; O'Malley BW
Mol Endocrinol; 2011 Dec; 25(12):2041-53. PubMed ID: 22053001
[TBL] [Abstract][Full Text] [Related]
3. Development of improved SRC-3 inhibitors as breast cancer therapeutic agents.
Qin L; Chen J; Lu D; Jain P; Yu Y; Cardenas D; Peng X; Yu X; Xu J; Wang J; O'Malley BW; Lonard DM
Endocr Relat Cancer; 2021 Aug; 28(10):657-670. PubMed ID: 34310341
[TBL] [Abstract][Full Text] [Related]
4. Identification of verrucarin a as a potent and selective steroid receptor coactivator-3 small molecule inhibitor.
Yan F; Yu Y; Chow DC; Palzkill T; Madoux F; Hodder P; Chase P; Griffin PR; O'Malley BW; Lonard DM
PLoS One; 2014; 9(4):e95243. PubMed ID: 24743578
[TBL] [Abstract][Full Text] [Related]
5. Bufalin is a potent small-molecule inhibitor of the steroid receptor coactivators SRC-3 and SRC-1.
Wang Y; Lonard DM; Yu Y; Chow DC; Palzkill TG; Wang J; Qi R; Matzuk AJ; Song X; Madoux F; Hodder P; Chase P; Griffin PR; Zhou S; Liao L; Xu J; O'Malley BW
Cancer Res; 2014 Mar; 74(5):1506-1517. PubMed ID: 24390736
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.
Wang L; Yu Y; Chow DC; Yan F; Hsu CC; Stossi F; Mancini MA; Palzkill T; Liao L; Zhou S; Xu J; Lonard DM; O'Malley BW
Cancer Cell; 2015 Aug; 28(2):240-52. PubMed ID: 26267537
[TBL] [Abstract][Full Text] [Related]
7. Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer.
Lee WK; Kim WG; Fozzatti L; Park S; Zhao L; Willingham MC; Lonard D; O'Malley BW; Cheng SY
Endocr Relat Cancer; 2020 Apr; 27(4):209-220. PubMed ID: 31977311
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissue.
Haugan Moi LL; Hauglid Flågeng M; Gandini S; Guerrieri-Gonzaga A; Bonanni B; Lazzeroni M; Gjerde J; Lien EA; DeCensi A; Mellgren G
Clin Cancer Res; 2010 Apr; 16(7):2176-86. PubMed ID: 20332317
[TBL] [Abstract][Full Text] [Related]
10. Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells.
Rohira AD; Yan F; Wang L; Wang J; Zhou S; Lu A; Yu Y; Xu J; Lonard DM; O'Malley BW
Cancer Res; 2017 Aug; 77(16):4293-4304. PubMed ID: 28611048
[TBL] [Abstract][Full Text] [Related]
11. Identification of target genes in breast cancer cells directly regulated by the SRC-3/AIB1 coactivator.
Labhart P; Karmakar S; Salicru EM; Egan BS; Alexiadis V; O'Malley BW; Smith CL
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1339-44. PubMed ID: 15677324
[TBL] [Abstract][Full Text] [Related]
12. Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug.
Song X; Zhang C; Zhao M; Chen H; Liu X; Chen J; Lonard DM; Qin L; Xu J; Wang X; Li F; O'Malley BW; Wang J
PLoS One; 2015; 10(10):e0140011. PubMed ID: 26431029
[TBL] [Abstract][Full Text] [Related]
13. SRC-3, a Steroid Receptor Coactivator: Implication in Cancer.
Li L; Deng CX; Chen Q
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946224
[TBL] [Abstract][Full Text] [Related]
14. A genome-scale CRISPR Cas9 dropout screen identifies synthetically lethal targets in SRC-3 inhibited cancer cells.
Gilad Y; Eliaz Y; Yu Y; Dean AM; Han SJ; Qin L; O'Malley BW; Lonard DM
Commun Biol; 2021 Mar; 4(1):399. PubMed ID: 33767353
[TBL] [Abstract][Full Text] [Related]
15. SRC-3 has a role in cancer other than as a nuclear receptor coactivator.
Ma G; Ren Y; Wang K; He J
Int J Biol Sci; 2011; 7(5):664-72. PubMed ID: 21647249
[TBL] [Abstract][Full Text] [Related]
16. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.
Rohira AD; Lonard DM
Biochem Pharmacol; 2017 Sep; 140():1-7. PubMed ID: 28390937
[TBL] [Abstract][Full Text] [Related]
18. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
19. miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.
Eedunuri VK; Rajapakshe K; Fiskus W; Geng C; Chew SA; Foley C; Shah SS; Shou J; Mohamed JS; Coarfa C; O'Malley BW; Mitsiades N
Mol Endocrinol; 2015 Aug; 29(8):1170-83. PubMed ID: 26066330
[TBL] [Abstract][Full Text] [Related]
20. SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: is there enough coactivator to go around in cells?
Lonard DM; O'Malley BW
Sci Signal; 2008 Apr; 1(13):pe16. PubMed ID: 18385039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
